AMGN vs WEX · P/E 24, rev $10.05B vs P/E 14, rev $1.43B
Amgen Inc (AMGN) versus Wex Inc (WEX) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Wex Inc (WEX) is a software - infrastructure company listed on NYSE.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported WEX revenue for 2026-06-30 was $1.43B. Net income was $186.2M. WEX currently screens at market cap $4.40B and trailing P/E 14.3.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. WEX currently screens at market cap $4.40B and trailing P/E 14.3.
Not investment advice. Open the AMGN and WEX stock pages for the full models.
Not investment advice.